Atrial Fibrillation Trial, Recruiting NCT07085650 Sponsor: First Hospital of China Medical University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07085650
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have come to hospital with atrial fibrillation (an irregular heartbeat condition) and are planning to have an ablation procedure (a treatment that uses energy to correct the abnormal heart rhythm)

Who may not be able to join:

  • People who have a history of blood clots in the left side of the heart, or who have had a stroke or heart attack within the last 6 months
  • People with certain heart conditions, including congenital heart disease (a heart condition present from birth), heart valve disease, dilated heart disease, hypertrophic cardiomyopathy (a thickened heart muscle condition), a pacemaker already in place, or an artificial heart valve
  • People with an overactive thyroid, or severe liver or kidney problems
  • People who are already scheduled to have a heart pacemaker implanted
  • People who have previously had a catheter ablation procedure for their heart
  • People whose three-dimensional heart imaging (taken via a camera passed down the throat) was not clear enough to be analysed (confirm with trial site)
  • People who do not wish to sign the consent form to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13998816448

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Hospital of China Medical University
Registry
ClinicalTrials.gov
Start date
30 December 2024
Est. completion
31 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Recurrence of atrial fibrillation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov